A new meta-analysis of controlled clinical trials shows the antidepressant and anxiolytic potential of probiotics
4 Jun 2019by GMFH Editing Team
To what extent targeting the gut microbiota as a potential treatment for depression and anxiety is unknown. A new systematic review and meta-analysis of 34 controlled clinical trials concludes that probioticsbut not prebioticsmay exert potential antidepressant and anxiolytic effects.